Obesity and suppressed B-type natriuretic peptide levels in heart failure.
about
Cardiopulmonary laboratory biomarkers in the evaluation of acute dyspneaNatriuretic Peptides in the Regulation of Cardiovascular Physiology and Metabolic EventsMorbid obesity: obscuring the diagnosis of aortic stenosis in a patient with cardiogenic wheezingObesity paradox in heart failure: a heavy matter.Obesity, Heart Failure, and Obesity ParadoxChronic heart failure: contemporary diagnosis and managementBiomarkers and cardiovascular risk assessment for primary prevention: an update.Association between direct measures of body composition and prognostic factors in chronic heart failure.Cardiac remodeling in obesity.Serum A-FABP is increased and closely associated with elevated NT-proBNP levels in type 2 diabetic patients treated with rosiglitazone.Plasma levels of alpha-1-antichymotrypsin are elevated in patients with chronic heart failure, but are of limited prognostic value.Relationship between obesity and N-terminal brain natriuretic Peptide level as a prognostic value after acute myocardial infarction.Can low brain-derived neurotrophic factor levels be a marker of the presence of depression in obese women?Effects of coronary ischemia-reperfusion in a rat model of early overnutrition. Role of angiotensin receptors.The association between daily physical activity and plasma B-type natriuretic peptide in patients with glucose intolerance: a cross-sectional study.Obesity and hypertension, heart failure, and coronary heart disease-risk factor, paradox, and recommendations for weight lossNatriuretic peptides in the diagnosis and management of heart failurePreventive cardiology and non-invasive cardiology research at the ochsner clinic foundationDiagnosis and management of heart failure with preserved ejection fraction: 10 key lessonsWeight and mortality following heart failure hospitalization among diabetic patients.Brain natriuretic peptide release in acute myocardial infarction.Effect of weight loss after weight loss surgery on plasma N-terminal pro-B-type natriuretic peptide levels.Relationship between N-terminal pro-B-type natriuretic peptide levels and metabolic syndromeIdentifying biomarker patterns and predictors of inflammation and myocardial stress.Cardiac natriuretic peptides in plasma increase after dietary induced weight loss in obesity.Downregulation in GATA4 and Downstream Structural and Contractile Genes in the db/db Mouse HeartRelation of obesity to circulating B-type natriuretic peptide concentrations in blacks: the Jackson Heart Study.BNP Consensus Panel 2004: A clinical approach for the diagnostic, prognostic, screening, treatment monitoring, and therapeutic roles of natriuretic peptides in cardiovascular diseases.Brain natriuretic peptide in the contemporary management of congestive heart failure.Prevalence, clinical phenotype, and outcomes associated with normal B-type natriuretic peptide levels in heart failure with preserved ejection fractionMonitoring of patients with heart failure.Cardiac endocrine function is an essential component of the homeostatic regulation network: physiological and clinical implications.Cardiovascular and metabolic effects of natriuretic peptides.Obesity and the response to intensified diuretic treatment in decompensated heart failure: a DOSE trial substudyImpact of the look AHEAD intervention on NT-pro brain natriuretic peptide in overweight and obese adults with diabetes.N-Terminal Pro-Brain Natriuretic Peptide and Heart Failure Risk Among Individuals With and Without Obesity: The Atherosclerosis Risk in Communities (ARIC) Study.B-type natriuretic peptide: a critical review.Nonheart failure-associated elevation of amino terminal pro-brain natriuretic peptide in the setting of sepsis.Combining tissue Doppler echocardiography and B-type natriuretic peptide in the evaluation of left ventricular filling pressures: review of the literature and clinical recommendationsEffects of interleukin-1 blockade with anakinra on aerobic exercise capacity in patients with heart failure and preserved ejection fraction (from the D-HART pilot study)
P2860
Q26745756-276309CA-5850-4BB7-865E-3705EEAD7BEDQ26778333-48B74742-6F55-4479-973C-495C174286F3Q27005608-68881036-2474-4601-A8A6-3A43D53ABC43Q28074729-6868586D-176E-479E-83AC-7007F174F2FCQ33617505-F9720E40-3D25-4032-A232-8A2610BB8EB5Q33620431-A2784E5F-78AD-4C6C-A9B5-A6BFC5FFAD04Q33927398-FF2162E3-B6E9-43F5-88D0-9101BE6AC52EQ33951525-1DBDD15A-99DF-40B0-85AF-38216A092E27Q34043589-E832D907-8040-47CF-9E6D-21E33EB2678EQ34064920-B38CA120-5574-4BEC-B01C-E1179D918FE8Q34161212-14DF2F23-C02C-4F4A-97CD-F1690CC20771Q34434691-FCA499C4-C42D-4BE1-B10A-68EF368B3640Q34482471-A419311C-6CC0-408F-BA39-610778965DD7Q34577046-31A8E74C-AEF4-4BE4-92DB-665C284CCDADQ34981484-B8A95B62-7D9F-40DF-B69C-7D6903F30C47Q34986366-9BB84183-4FDA-4439-B481-A36C80D3AD5FQ35015563-0BC0F875-6156-47C6-A2C9-790C03D83632Q35080241-4E0E88F4-DBD9-4EAD-9033-1208F3F90265Q35139959-43BE9217-3E77-41CF-8E0C-BABF36E3F8BAQ35178168-940AE8CE-3611-4FC4-A8BE-AAF59287F7ABQ35184348-C91D041B-8BC1-4F2F-BAAD-AE393DC79ADEQ35207709-0FCE5A80-B0C9-4246-909A-6CC83DED593BQ35674117-C70BC476-2AA6-4B75-9DD1-9F996E45AADBQ35685066-70D18C72-7251-45CB-9077-2959640AFA28Q35718443-76545A32-AE75-4D06-AC70-68E57C69F58BQ35855603-753F8B79-569E-4601-8743-E22564B8BBACQ35868835-7FE41487-1CDC-4FDF-A156-1E76BC53D722Q35987052-87509235-D82D-49AD-B0AD-4123CCB074DFQ36050481-51FEA5A8-9A84-4287-914B-5A9DBBE785D7Q36203267-3FD0AB5A-34E0-4B0E-A081-7C05F3C412BFQ36236505-FA7A7DC1-9BA4-4EA1-A0AD-22DD331EBA07Q36350919-E6288136-E7F2-42B7-A251-F5FD1ED58A4AQ36382621-89370F34-1567-41DB-9F3F-BEADD08E7F6BQ36399698-1C54B40C-C06A-4BD9-8F47-032F16371B4BQ36433506-77FF4CA5-8F36-4385-B99F-616C35E89637Q36593924-C5A54CB8-013C-4997-A5A8-290A3FE43CD4Q36724549-D69B09D5-5DDB-42C2-B4AD-65D6DB18B07AQ36861287-7049CD2D-D1B3-444D-80E6-370C81E77B69Q36969041-94F43DE9-D7B1-485F-8DE3-BBBDD826F375Q36985609-D3A6A735-DDC8-4317-87B9-838C6B19997B
P2860
Obesity and suppressed B-type natriuretic peptide levels in heart failure.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Obesity and suppressed B-type natriuretic peptide levels in heart failure.
@en
Obesity and suppressed B-type natriuretic peptide levels in heart failure.
@nl
type
label
Obesity and suppressed B-type natriuretic peptide levels in heart failure.
@en
Obesity and suppressed B-type natriuretic peptide levels in heart failure.
@nl
prefLabel
Obesity and suppressed B-type natriuretic peptide levels in heart failure.
@en
Obesity and suppressed B-type natriuretic peptide levels in heart failure.
@nl
P2093
P1476
Obesity and suppressed B-type natriuretic peptide levels in heart failure.
@en
P2093
Bobbett C Harris
Edward D Frohlich
Hector O Ventura
Myung H Park
Patricia A Uber
Robert L Scott
P304
P356
10.1016/J.JACC.2003.10.066
P407
P577
2004-05-01T00:00:00Z